ARCHIVES

FDA, NCI, CMS Announce Biomarker Initiative; First Project To Validate FDG-PET As Predictor Of Tumor Response In Non-Hodgkin’s Lymphoma.

This article is from The Cancer Letter archive.

Vol. 32 No. 06 | February 17, 2006

Download PDF Visit The Full Archive

Related Articles

Mouse Strains For Retrovirus Research Available From NCU

March 23, 1984

Klausner Reaffirms NCI’s “No. 1 Priority” Is Funding investigator-Initiated Research

September 13, 1996

Groups Urge FDA To Take Action Against Tobacco Products

June 27, 2014

ODAC Recommendation for Pertuzumab Signals FDA’s Resolve In Granting Accelerated Approvals

September 20, 2013

In Brief: GM Prizes To Withers, Cory, Korsmeyer, Horvitz; Univ. of Chicago, City of Hope Are Comprehensive

May 1, 1998

In the States: Michigan to Allocate $50 Million Annually To Life Sciences

July 23, 1999